Literature DB >> 26583697

Hendra Virus Infection in Dog, Australia, 2013.

Peter D Kirkland, Melinda Gabor, Ian Poe, Kristie Neale, Kim Chaffey, Deborah S Finlaison, Xingnian Gu, Paul M Hick, Andrew J Read, Therese Wright, Deborah Middleton.   

Abstract

Hendra virus occasionally causes severe disease in horses and humans. In Australia in 2013, infection was detected in a dog that had been in contact with an infected horse. Abnormalities and viral RNA were found in the dog's kidney, brain, lymph nodes, spleen, and liver. Dogs should be kept away from infected horses.

Entities:  

Keywords:  Australia; Hendra virus; dog; natural infection; pathology; virology; viruses

Mesh:

Year:  2015        PMID: 26583697      PMCID: PMC4672422          DOI: 10.3201/eid2112.151324

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Hendra virus (HeV) is a paramyxovirus (genus Henipavirus) () that causes respiratory and neurologic disease in horses and humans; the case-fatality rate is >60%. Fruit bats are the reservoir hosts (,) and excrete virus in urine (). Disease outbreaks among horses occur sporadically along the eastern coast of Queensland and New South Wales, Australia. Infection of veterinarians after close contact with infected horses presents a serious occupational hazard. After confirmation of Hendra infection in horses, an affected farm is quarantined by animal health authorities. All horses, cats, and dogs determined to be at risk for infection are monitored for clinical signs and tested for virus until they are no longer considered to be potentially infected. Cats and dogs are included in this surveillance because they have been shown to be susceptible to experimental infection with HeV (; D. Middleton, unpub. data). In July 2013, during investigation of HeV infection in a horse near Macksville, New South Wales, Australia, infection was also detected in a dog on the same farm.

The Study

The infected horse was a 6-year-old Australian stock horse gelding. HeV RNA was detected by quantitative reverse transcription PCR (qRT-PCR) in EDTA-treated blood (cycle threshold [Ct] 26.82), serum (Ct 30.87), and nasal swab samples (Ct 34.56) collected on July 4, 2013. Later that day, the horse was killed by shooting. During follow-up investigations on July 6, negative HeV results (qRT-PCR and ELISA) were obtained from whole blood, serum, and nasal swab samples collected from 2 additional horses; whole blood and oral swab samples collected from 2 dogs; and oral swab samples collected from a third dog. These dogs were from the same farm as the HeV-positive horse. Twelve days later, additional blood samples were collected (placed in EDTA or allowed to clot) from the 3 dogs, and oral swab samples were collected from 1 of these dogs (a 6-year-old cross-bred female fox terrier). HeV RNA was detected in the EDTA-treated blood (Ct 31.48) and serum (Ct 34.01), but not from the oral swab samples, from this dog. Results from all samples from the other dogs were negative by qRT-PCR and ELISA. Serum from the dog with positive results by qRT-PCR gave a weak positive result by ELISA and a virus neutralization titer of 8. The dog showed no signs of ill health, although it had winced several times, suggesting discomfort or pain. Because the transmission risk posed by the dog was uncertain, it was euthanized 14 days after collection of the first samples. Blood (placed in EDTA or allowed to clot); oral, nasal, rectal, and vaginal swab samples; and urine were collected immediately thereafter. The cadaver was immediately transported to the laboratory, and a postmortem examination was conducted later that day. No external gross abnormalities were detected. Internal examination revealed diffuse marked reddening of all lung lobes and overlying dark patchy discoloration of dependent lobes; abundant frothy tracheal and bronchial fluid; enlargement and diffuse reddening of bronchial, tracheobronchial, and mandibular lymph nodes; prominent and diffuse reddening of both tonsils; and prominent white streaks at the corticomedullary junction of both kidneys. The spleen and liver were enlarged with rounded edges, and the liver had a mild cobblestone pattern (Table 1). Histopathology findings closely aligned with gross findings; lesions in the brain were also histologically detected. The predominant lesion, found in decreasing severity in kidney, brain, lymph nodes, spleen, liver, intestine, and lung, was fibrinoid necrosis of vessels with marked segmental to diffuse vasculitis, disruption of subendothelial tunica intima, and expansion with thick bands of deeply eosinophilic hyaline to fibrinoid material admixed with karyorrhectic debris and degenerate neutrophils (Figure 1). Surrounding inflammatory infiltrates (plasma cells, lymphocytes, and karyorrhectic debris) often effaced and replaced surrounding normal structures. Cerebral and cerebellar meninges were moderately expanded with lymphocytes, plasma cells, and macrophages (Figure 2), and cerebral vasculitis was associated with surrounding malacia. Pulmonary alveoli were flooded with lightly eosinophilic fluid (edema) containing scattered erythrocytes, plasma cells, and macrophages. Hepatocytes were diffusely expanded, and floccular vacuolation was compressing adjacent sinusoids. Small amounts of viral antigen were detected in a necrotic glomerulus and within the media of a renal arteriole by immunoperoxidase staining.
Table 1

Gross and histopathologic findings in tissues of Hendra virus–infected dog, Australia, 2013*

SampleGross pathologyHistopathology
PharynxNDNSF
Soft palateNDNSF
Tonsil
Moderate
NA
Lymph node
SubmandibularNDNSF
MandibularMildNSF
BronchialModerateModerate
TracheobronchialModerateModerate
AxillaryNDNSF
Inguinal
ND
NSF
LungModerateMild
MyocardiumMildMild
SpleenMildMild
LiverMildMild
KidneyModerateMarked
Adrenal glandNDNSF
Bladder
ND
NSF
Intestine
SmallNDNSF
Large
ND
Mild
Brain
OlfactoryNDModerate
OccipitalNDModerate
CerebellumNDModerate
Brain stem
ND
Moderate
MeningesNDModerate
Spinal cordNDNA
TurbinateNDNSF
Trigeminal ganglionNDNA
Brachial nerveNDNA

*NA, tissue not available; ND, not detected; NSF, no significant changes found.

Figure 1

Kidney of dog infected with Hendra virus, showing marked vasculitis (arrow) and inflammatory infiltrates (*) effacing renal tubules (△). Scale bar indicates 75 μm.

Figure 2

Cerebellum of dog infected with Hendra virus, showing expansion of the meninges with inflammatory infiltrates (*) and marked vasculitis (arrow). Scale bar indicates 75 μm.

*NA, tissue not available; ND, not detected; NSF, no significant changes found. Kidney of dog infected with Hendra virus, showing marked vasculitis (arrow) and inflammatory infiltrates (*) effacing renal tubules (△). Scale bar indicates 75 μm. Cerebellum of dog infected with Hendra virus, showing expansion of the meninges with inflammatory infiltrates (*) and marked vasculitis (arrow). Scale bar indicates 75 μm. An extensive range of fresh tissues and swab samples were collected for testing by qRT-PCR, and HeV RNA was found in many of the tissues (Table 2). No virus was isolated from any of the tissues in cell culture. Serum collected at the time of euthanasia was positive by ELISA; virus neutralization titer was 128. All other animals on the farm remained seronegative when sampled 4 weeks after the infected dog had been euthanized. Laboratory methods are described in the Technical Appendix.
Table 2

Hendra virus RNA levels in tissues and blood of Hendra virus–infected dog, Australia, 2013*

SampleRNA level†
Blood (in EDTA)33.36
Pharynx36.52
Soft palate35.08
Tonsil
36.12
Lymph node
SubmandibularND
Mandibular33.91
Bronchial28.32
Tracheobronchial28.26
Axillary32.87
Inguinal
33.91
Spleen29.64
Lung35.00
Myocardium28.62
Liver27.65
Kidney29.03
Adrenal34.06
Bladder
33.68
Intestine
Small35.01
Large
ND
Spinal cord
28.67
Brain
Olfactory34.84
Occipital34.38
CerebellumND
Brain stem
ND
MeningesND
TurbinateND
Trigeminal ganglionND
Brachial nerveND

*ND, not detected. 
†Cycle threshold.

*ND, not detected. 
†Cycle threshold.

Conclusions

Dogs and cats have been infected with HeV under experimental conditions. Previously, a dog located on the same property as 3 infected horses in Queensland, Australia, was found to be seropositive () without having shown clinical signs. The dog reported in this article, which also remained clinically healthy, was naturally infected and was identified during the acute stages of infection. Viral RNA was detected in this animal 12 days after euthanasia of the clinically affected horse. The dog was known to have been in close contact with the live infected horse and is suspected of having been exposed to its blood after the horse was euthanized. The epidemiologic and laboratory evidence supports transmission of HeV from horse to dog. In horses naturally infected with HeV, the development of neutralizing antibodies is associated with virus clearance from the infected animal. The detection of seroconversion and rising neutralizing antibody titers in canine serum collected ≈14 and then 16 days after putative virus exposure is consistent with the early stages of HeV infection and aligns with the low viral RNA levels in blood and a wide range of tissues (the highest levels were found in liver, bronchial lymph node, kidney, and myocardium). Failure to isolate virus in cell culture was probably the result of increasing antibody levels. It is difficult to establish from the qRT-PCR results whether virus replication occurred in tissues such as kidney, liver, myocardium, and spinal cord or whether this finding represents residual RNA from blood. However, the levels in these sites were 10–100-fold higher than that in blood, suggesting either local replication or accumulation of viral RNA. Very low levels of viral RNA were detected in the soft palate, pharynx, and tonsil, although virus was not detected in nasal, oral, rectal, or vaginal swab samples and urine. The risk for transmission of HeV from infected dogs to other susceptible species—including humans—remains unknown. The histopathologic finding of widespread necrotizing vasculitis supports the current understanding of the pathogenesis of HeV infection, during which virus binds to the endothelial ephrin-B2 transmembrane protein receptor () and localizes in vessel walls, leading to endothelial cell damage. The most severe vascular lesions were found in kidney, brain, and lymph nodes; the lungs were relatively spared, and fulminant pulmonary edema and interstitial pneumonia were not significant findings in this case. The route of infection for the dog reported here is unknown, but the dog was in close contact with the infected horse and is suspected to have had contact with its blood. Because viral loads in acutely infected horses are usually very high, dogs can be readily infected and should be kept away from infected horses, which seem to be efficient amplifying hosts.

Technical Appendix

Additional laboratory methods used to detect Hendra virus in dog, Australia, 2013.
  6 in total

1.  Serologic evidence for the presence in Pteropus bats of a paramyxovirus related to equine morbillivirus.

Authors:  P L Young; K Halpin; P W Selleck; H Field; J L Gravel; M A Kelly; J S Mackenzie
Journal:  Emerg Infect Dis       Date:  1996 Jul-Sep       Impact factor: 6.883

2.  Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus.

Authors:  Matthew I Bonaparte; Antony S Dimitrov; Katharine N Bossart; Gary Crameri; Bruce A Mungall; Kimberly A Bishop; Vidita Choudhry; Dimiter S Dimitrov; Lin-Fa Wang; Bryan T Eaton; Christopher C Broder
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-05       Impact factor: 11.205

3.  Isolation of Hendra virus from pteropid bats: a natural reservoir of Hendra virus.

Authors:  K Halpin; P L Young; H E Field; J S Mackenzie
Journal:  J Gen Virol       Date:  2000-08       Impact factor: 3.891

4.  Susceptibility of cats to equine morbillivirus.

Authors:  H A Westbury; P T Hooper; S L Brouwer; P W Selleck
Journal:  Aust Vet J       Date:  1996-08       Impact factor: 1.281

5.  A morbillivirus that caused fatal disease in horses and humans.

Authors:  K Murray; P Selleck; P Hooper; A Hyatt; A Gould; L Gleeson; H Westbury; L Hiley; L Selvey; B Rodwell
Journal:  Science       Date:  1995-04-07       Impact factor: 47.728

6.  Identifying Hendra virus diversity in pteropid bats.

Authors:  Ina Smith; Alice Broos; Carol de Jong; Anne Zeddeman; Craig Smith; Greg Smith; Fred Moore; Jennifer Barr; Gary Crameri; Glenn Marsh; Mary Tachedjian; Meng Yu; Yu Hsin Kung; Lin-Fa Wang; Hume Field
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

  6 in total
  13 in total

1.  Hendra virus and Nipah virus animal vaccines.

Authors:  Christopher C Broder; Dawn L Weir; Peter A Reid
Journal:  Vaccine       Date:  2016-05-04       Impact factor: 3.641

Review 2.  Transmission of henipaviruses.

Authors:  Sarah Weatherman; Heinz Feldmann; Emmie de Wit
Journal:  Curr Opin Virol       Date:  2017-10-14       Impact factor: 7.090

3.  Serological Hendra Virus Diagnostics Using an Indirect ELISA-Based DIVA Approach with Recombinant Hendra G and N Proteins.

Authors:  Anne Balkema-Buschmann; Kerstin Fischer; Leanne McNabb; Sandra Diederich; Nagendrakumar Balasubramanian Singanallur; Ute Ziegler; Günther M Keil; Peter D Kirkland; Maren Penning; Balal Sadeghi; Glenn Marsh; Jennifer Barr; Axel Colling
Journal:  Microorganisms       Date:  2022-05-25

4.  Optimization and diagnostic evaluation of monoclonal antibody-based blocking ELISA formats for detection of neutralizing antibodies to Hendra virus in mammalian sera.

Authors:  A Di Rubbo; L McNabb; R Klein; J R White; A Colling; D S Dimitrov; C C Broder; D Middleton; R A Lunt
Journal:  J Virol Methods       Date:  2019-09-09       Impact factor: 2.014

5.  Rebuttal to Peel et al. Re: 'The imperative to develop a human vaccine for the Hendra virus in Australia'.

Authors:  Bilal Zahoor
Journal:  Infect Ecol Epidemiol       Date:  2016-05-04

6.  The equine Hendra virus vaccine remains a highly effective preventative measure against infection in horses and humans: 'The imperative to develop a human vaccine for the Hendra virus in Australia'.

Authors:  Alison J Peel; Hume E Field; Peter A Reid; Raina K Plowright; Christopher C Broder; Lee F Skerratt; David T S Hayman; Olivier Restif; Melanie Taylor; Gerardo Martin; Gary Crameri; Ina Smith; Michelle Baker; Glenn A Marsh; Jennifer Barr; Andrew C Breed; James L N Wood; Navneet Dhand; Jenny-Ann Toribio; Andrew A Cunningham; Ian Fulton; Wayne L Bryden; Cristy Secombe; Lin-Fa Wang
Journal:  Infect Ecol Epidemiol       Date:  2016-05-04

7.  Indirect ELISA based on Hendra and Nipah virus proteins for the detection of henipavirus specific antibodies in pigs.

Authors:  Kerstin Fischer; Sandra Diederich; Greg Smith; Sven Reiche; Vinicius Pinho Dos Reis; Eileen Stroh; Martin H Groschup; Hana M Weingartl; Anne Balkema-Buschmann
Journal:  PLoS One       Date:  2018-04-30       Impact factor: 3.240

Review 8.  Hendra virus: Epidemiology dynamics in relation to climate change, diagnostic tests and control measures.

Authors:  Ka Y Yuen; Natalie S Fraser; Joerg Henning; Kim Halpin; Justine S Gibson; Lily Betzien; Allison J Stewart
Journal:  One Health       Date:  2020-12-21

9.  Vaccines to Emerging Viruses: Nipah and Hendra.

Authors:  Moushimi Amaya; Christopher C Broder
Journal:  Annu Rev Virol       Date:  2020-09-29       Impact factor: 10.431

10.  Managing the risk of Hendra virus spillover in Australia using ecological approaches: A report on three community juries.

Authors:  Chris Degeling; Gwendolyn L Gilbert; Edward Annand; Melanie Taylor; Michael G Walsh; Michael P Ward; Andrew Wilson; Jane Johnson
Journal:  PLoS One       Date:  2018-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.